
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.62 | 0.62 | 0.00 |
Shares | 98.36 | 98.36 | 0.00 |
Convertible | 0.04 | 0.04 | 0.00 |
Preferred | 0.45 | 0.45 | 0.00 |
Other | 0.53 | 0.53 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.94 | 19.62 |
Price to Book | 4.14 | 4.36 |
Price to Sales | 1.60 | 2.36 |
Price to Cash Flow | 13.84 | 15.71 |
Dividend Yield | 1.34 | 1.14 |
5 Years Earnings Growth | 8.55 | 11.11 |
Number of long holdings: 106
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.87 | 839.87 | +2.44% | |
UnitedHealth | US91324P1021 | 4.52 | 360.20 | +1.83% | |
AstraZeneca | GB0009895292 | 4.15 | 12,650.0 | +1.57% | |
Boston Scientific | US1011371077 | 3.45 | 97.32 | +1.14% | |
Abbott Labs | US0028241000 | 3.42 | 134.59 | +1.20% | |
J&J | US4781601046 | 3.15 | 188.64 | +1.43% | |
Sanofi | FR0000120578 | 2.90 | 86.80 | +2.07% | |
Novartis ADR | US66987V1098 | 2.65 | 132.39 | +1.08% | |
Amgen | US0311621009 | 2.55 | 297.89 | +0.16% | |
AbbVie | US00287Y1091 | 2.52 | 233.91 | -1.12% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Research D | 19.32B | 13.02 | 27.29 | 15.66 | ||
Janus Balanced I | 12.51B | 10.54 | 13.06 | 9.98 | ||
Janus Enterprise I | 10.05B | 5.73 | 12.78 | 12.66 | ||
Janus Henderson Balanced Portfolio | 8.87B | 10.45 | 12.84 | 9.70 | ||
Janus Enterprise N | 7B | 5.79 | 12.89 | 12.77 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review